[1] 徐倩, 杨颖, 柳洋,等. 不同种类降糖药物对2型糖尿病患者血清胰岛素样生长因子1及胰岛素样生长因子结合蛋白3水平的影响[J]. 中国医药, 2016, 11(7):1015-1019. [2] Ren S, Nie Y, Wang A. Effects of recombinant human growth hormone in the treatment of dwarfism and relationship between IGF-1, IGFBP-3 and thyroid hormone[J]. Exp TherMed, 2016, 12(6):3579-3582. [3] 叶昀, 牛朝诗, 杨洋,等. 胶质瘤中IGF-1和IGFBP-3的表达及临床意义研究[J]. 安徽医科大学学报, 2016, 51(2):231-234. [4] 范良华. 小于胎龄矮小患儿生长激素治疗与IGF-1及IGFBP-3水平的相关研究[J]. 浙江中西医结合杂志, 2016, 26(6):558-560. [5] 宋姗姗, 杨博逸, 孙韶龙,等. 血清胰岛素样生长因子-1和胰岛素样生长因子结合蛋白-3水平与胰腺癌及大肠癌发生风险相关性的Meta分析[J]. 中国慢性病预防与控制, 2015, 23(1):37-41. [6] 季翠红. 窒息新生儿检测血清胰岛素样生长因子-1及其结合蛋白-3和Ghrelin的意义[J]. 现代中西医结合杂志, 2016, 25(8):825-827. [7] 郝尧. 健脾益肾法联合重组人生长激素治疗特发性矮小症的疗效及对血清IGF-1、IGFBP-3表达的影响[J]. 现代中西医结合杂志, 2015, 24(26):2900-2902. [8] 宋叶梅, 郁峰. 重组人生长激素治疗儿童特发性矮小症效果及对胰岛素生长因子的影响[J]. 中国乡村医药, 2016, 23(10):9-10. [9] Wikiera B, Zawadzka K, Baczmański L, et al. Growth hormone treatment increases plasma irisin concentration in patients with turner syndrome[J]. Hormonesot Metabolisme, 2017, 49(2):122-128. [10] Sanges N. Walleye growth in relation to alewife Abundance in Otsego Lake, New York[J]. Adv Ther, 2015, 26(1):40-54. [11] Spinas E, Saggini A, Kritas S K, et al. Can vitamin a mediate immunity and inflammation?[J]. J Biol Regul Homeost Agents, 2015, 29(1):1-6. [12] Poyrazoglu S, Akçay T, Arslanoglu I, et al. Current practice in diagnosis and treatment of growth hormone deficiency in childhood:a survey from Turkey.[J]. J Clin Res Pediatr Endocrinol, 2015, 7(1):37-44. [13] Qie D, Yang F. Efficacy of different doses of recombinant human growth hormone in the treatment of short stature in children born small for gestational age[J]. Chin J Contemp Pediatr, 2016, 18(3):247-253. [14] 马迪, 宁丰. GH、IGF-1、IGFBP3与妊娠期糖尿病的关系及对新生儿生长的影响[J]. 中国继续医学教育, 2016, 8(29):81-82. [15] 张楠, 周永焘, 刘金煜. 老年男性骨质疏松患者血清瘦素、胰岛素样生长因子-1和胰岛素样生长因子结合蛋白-3表达的临床意义[J]. 中国老年学, 2016, 36(9):2142-2144. |